Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Ultragenyx Pharmaceutical Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 69.58||$ 137.05|
|Low||$ 65.54||$ 49|
The current last sale of $69.46 is 41.76% Higher thanthe 52 week low.
ETFs with RARE as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|0.48%||Vanguard Russell 2000 Growth ETF (VTWG)||-8.40 (-7.95%)|
|0.24%||Vanguard Russell 2000 ETF (VTWO)||-4.32 (-4.58%)|
Company Description (as filed with the SEC)
We are a clinical-stage biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. We target diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no currently approved therapies. Since our inception in 2010, we have in-licensed potential treatments for multiple rare genetic disorders. Our strategy, which is predicated upon time- and cost-efficient drug development, allows us to pursue multiple programs in parallel with the goal of delivering safe and effective therapies to patients with the utmost urgency. Our current product candidate pipeline has been either in-licensed from academic institutions or derived from partnerships with other pharmaceutical companies. ... More ...
Where does RARE fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-3.96|
|Quarterly EPS Est:||-1.29|